Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America

NCT01057901 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

748

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated for administrative reasons.

Conditions

Sexual Dysfunctions, Psychological

Interventions

DRUG: Flibanserin
DRUG: Placebo

Sponsor

Sprout Pharmaceuticals, Inc